Note: Generex has a huge head start already funded by the Chinese. They will be able to test in China with less restrictions vs the FDA. Human trials in China with prior exposure to Covid -19 will start almost immediately. The vaccine if successful will put pressure for FDA Approval and a huge upside for Generex.
Epivax Info: Generex Partner EpiVax doing lab work both in Wuhan, China and Ross Labs at the University of Georgia.
EpiVax worked for 21 years to be able to make a vaccine in 24 hours!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.